Ultralife Current Deferred Revenue from 2010 to 2026
| ULBI Stock | USD 6.58 0.05 0.77% |
Current Deferred Revenue | First Reported 2001-06-30 | Previous Quarter -11.2 M | Current Value 298 K | Quarterly Volatility 4.8 M |
Check Ultralife financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ultralife's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.9 M, Interest Expense of 1.3 M or Total Revenue of 198.6 M, as well as many indicators such as Price To Sales Ratio of 0.82, Dividend Yield of 0.0 or PTB Ratio of 1.99. Ultralife financial statements analysis is a perfect complement when working with Ultralife Valuation or Volatility modules.
Ultralife | Current Deferred Revenue | Build AI portfolio with Ultralife Stock |
The Current Deferred Revenue trend for Ultralife offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Ultralife is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Ultralife's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Ultralife over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Ultralife's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ultralife's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Ultralife Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 1,675,179 | |
| Geometric Mean | 721,501 | |
| Coefficient Of Variation | 175.36 | |
| Mean Deviation | 2,371,525 | |
| Median | 119,000 | |
| Standard Deviation | 2,937,616 | |
| Sample Variance | 8.6T | |
| Range | 7.8M | |
| R-Value | 0.66 | |
| Mean Square Error | 5.2T | |
| R-Squared | 0.43 | |
| Significance | 0 | |
| Slope | 381,923 | |
| Total Sum of Squares | 138.1T |
Ultralife Current Deferred Revenue History
About Ultralife Financial Statements
Investors use fundamental indicators, such as Ultralife's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Ultralife's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 7 M | 7.4 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Ultralife Correlation against competitors. For more detail on how to invest in Ultralife Stock please use our How to Invest in Ultralife guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is there potential for Electrical Components & Equipment market expansion? Will Ultralife introduce new products? Factors like these will boost the valuation of Ultralife. If investors know Ultralife will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Ultralife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.72) | Earnings Share 0.1 | Revenue Per Share | Quarterly Revenue Growth 0.215 | Return On Assets |
Ultralife's market price often diverges from its book value, the accounting figure shown on Ultralife's balance sheet. Smart investors calculate Ultralife's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Ultralife's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Ultralife's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultralife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultralife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.